(NASDAQ: ARAY) Accuray's forecast annual revenue growth rate of 4.94% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Accuray's revenue in 2024 is $447,482,000.On average, 2 Wall Street analysts forecast ARAY's revenue for 2024 to be $45,964,722,578, with the lowest ARAY revenue forecast at $45,835,803,183, and the highest ARAY revenue forecast at $46,093,641,972. On average, 2 Wall Street analysts forecast ARAY's revenue for 2025 to be $48,766,240,189, with the lowest ARAY revenue forecast at $48,662,112,986, and the highest ARAY revenue forecast at $48,870,367,392.
In 2026, ARAY is forecast to generate $51,924,765,354 in revenue, with the lowest revenue forecast at $51,924,765,354 and the highest revenue forecast at $51,924,765,354.